Literature DB >> 29023959

Pembrolizumab for metastatic hepatocellular carcinoma following live donor liver transplantation: The silver bullet?

Ashwin Rammohan1, Mettu S Reddy1, Mohammed Farouk1, Joy Vargese1, Mohamed Rela1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29023959     DOI： 10.1002/hep.29575

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  15 in total

Review 1.  Liver graft rejection following immune checkpoint inhibitors treatment: a review.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Med Oncol       Date:  2019-10-11       Impact factor: 3.064

2.  The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.

Authors:  Ioannis A Ziogas; Alexandros P Evangeliou; Lipika Goyal; Georgios Tsoulfas; Dimitrios Giannis; Muhammad H Hayat; Konstantinos S Mylonas; Samer Tohme; David A Geller; Nahel Elias
Journal:  Oncologist       Date:  2021-01-02

Review 3.  Cutaneous squamous cell carcinoma in the organ transplant recipient.

Authors:  Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H L Kurten; Charles B Wessel; Heath Skinner; Dan P Zandberg
Journal:  Oral Oncol       Date:  2020-02-14       Impact factor: 5.337

4.  The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Authors:  Vivek Kumar; Atul B Shinagare; Helmut G Rennke; Sandeep Ghai; Jochen H Lorch; Patrick A Ott; Osama E Rahma
Journal:  Oncologist       Date:  2020-02-11

Review 5.  Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Authors:  Li-Wei Qiu; Yi-Fei Liu; Xiao-Qing Cao; Yan Wang; Xiao-Hong Cui; Xian Ye; Shuo-Wen Huang; Hong-Jun Xie; Hai-Jian Zhang
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

6.  Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.

Authors:  Thomas T DeLeon; Marcela A Salomao; Bashar A Aqel; Mohamad B Sonbol; Raquel T Yokoda; Ahmad H Ali; Adyr A Moss; Amit K Mathur; David M Chascsa; Jorge Rakela; Alan H Bryce; Mitesh J Borad
Journal:  J Gastrointest Oncol       Date:  2018-12

7.  Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Authors:  Zi-Yun Qiao; Zi-Jie Zhang; Zi-Cheng Lv; Huan Tong; Zhi-Feng Xi; Hao-Xiang Wu; Xiao-Song Chen; Lei Xia; Hao Feng; Jian-Jun Zhang; Qiang Xia
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 7.561

8.  Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Authors:  Dimitri Gassmann; Stefan Weiler; Joachim C Mertens; Cäcilia S Reiner; Bart Vrugt; Mirjam Nägeli; Joanna Mangana; Beat Müllhaupt; Fabienne Jenni; Benjamin Misselwitz
Journal:  Transplant Direct       Date:  2018-07-20

Review 9.  Review article: systemic treatment of hepatocellular carcinoma.

Authors:  Matthias Pinter; Markus Peck-Radosavljevic
Journal:  Aliment Pharmacol Ther       Date:  2018-07-23       Impact factor: 8.171

Review 10.  Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.

Authors:  Yi Luo; Fei Teng; Hong Fu; Guo-Shan Ding
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.